{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:17:11Z","timestamp":1789139831755,"version":"build-2803163510"},"reference-count":35,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Patients with chronic hypoparathyroidism are at increased risk of kidney complications. Also, chronic kidney disease is associated with increased cardiovascular risk. The aim was to analyze the factors that influence kidney function, including cardiovascular diseases (CVD), in a cohort of patients with chronic hypoparathyroidism. Methods: This was a retrospective longitudinal study that included 100 patients with chronic hypoparathyroidism. Results: The estimated glomerular filtration rate (eGFR) was associated with the duration of disease (p = 0.014). During follow-up, a significant decrease in eGFR was observed over time (p &lt; 0.001), and changes in the eGFR were associated with the duration of disease (p &lt; 0.001). We found that the eGFR was lower in patients with urolithiasis (p = 0.003), hypertension (p &lt; 0.001), type 2 diabetes (p = 0.031) and dyslipidemia (p &lt; 0.001). In total, 14% of patients had a chronic kidney disease (CKD), and these patients had a longer duration of disease (p &lt; 0.001). The percentage of patients with urolithiasis (p = 0.003), nephrocalcinosis (p = 0.008), hypertension (p = 0.005), type 2 diabetes (p &lt; 0.001), dyslipidemia (p &lt; 0.001), coronary heart disease (p = 0.008), and arrhythmia (p &lt; 0.001) was higher in patients with CKD. Logistic regression models showed that disease duration was associated with CKD (OR = 1.11; 95% CI [1.03\u20131.22]; p = 0.008). We used ROC curves to assess the usefulness of disease duration as a marker of CKD, and the AUC was 0.850 (95% CI 0.763\u20130.937, p &lt; 0.001). A duration of disease &gt; 15.5 years had a sensitivity of 85.7% and a specificity of 71.9% for a diagnosis of CKD. Conclusions: The duration of disease appears to be a predictor of the presence of renal dysfunction in patients with chronic hypoparathyroidism. In addition, the coexistence of CVD factors could result in greater renal damage.<\/jats:p>","DOI":"10.3390\/jcm14165732","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:30:38Z","timestamp":1755091838000},"page":"5732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors Related to Decline of Renal Function in Patients with Chronic Hypoparathyroidism"],"prefix":"10.3390","volume":"14","author":[{"given":"Elena","family":"L\u00f3pez-Mezquita Torres","sequence":"first","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-9942","authenticated-orcid":false,"given":"Antonia","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"},{"name":"Department of Medicine, University of Granada, 18016 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7452-4387","authenticated-orcid":false,"given":"Mar\u00eda del Carmen","family":"Andreo-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Contreras-Bol\u00edvar","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Garc\u00eda-Fontana","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-5561","authenticated-orcid":false,"given":"Beatriz","family":"Garc\u00eda-Fontana","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-3260","authenticated-orcid":false,"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Unit, University Hospital Cl\u00ednico San Cecilio, 18016 Granada, Spain"},{"name":"Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), 28029 Madrid, Spain"},{"name":"Department of Medicine, University of Granada, 18016 Granada, Spain"},{"name":"Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jbmr.4714","article-title":"Etiology and pathophysiology of hypoparathyroidism: A narrative review","volume":"37","author":"Pasieka","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/jbmr.4673","article-title":"Complications, symptoms, presurgical predictors in patients with chronic hypoparathyroidism: A systematic review","volume":"37","author":"Yao","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11154-020-09613-1","article-title":"Renal complications in patients with chronic hypoparathyroidism on conventional therapy: A systematic literature review","volume":"22","author":"Gosmanova","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from de second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cen.14470","article-title":"Determinants of hipercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study","volume":"95","author":"Ridder","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12325-021-01649-2","article-title":"Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism: A retrospective cohort study","volume":"38","author":"Ketteler","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","article-title":"Palopegteriparatide treatment improves renal function in adults with chronic hypoparathyroidism: 1-year results from the phase 3 PaTHway trial","volume":"41","author":"Rejnmark","year":"2024","journal-title":"Adv. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yao, J., Dong, Z., Wang, Q., Li, Z., Zhang, W., Lin, W., Luo, Y., Li, H., Guo, X., and Zhang, L. (2023). Clinical factors associated with arterial stiffness in chronic kidney disease. J. Clin. Med., 12.","DOI":"10.3390\/jcm12031077"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00198-015-3460-z","article-title":"Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries","volume":"27","author":"Benson","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCRESAHA.110.219899","article-title":"Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt\/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis","volume":"107","author":"Cheng","year":"2010","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cen.13927","article-title":"Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort study","volume":"90","author":"Underbjerg","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ejendo\/lvaf023","article-title":"Cardiovascular status in chronic hypoparathyroidism: A systematic cross-sectional assessment in 168 patients","volume":"192","author":"Fuss","year":"2025","journal-title":"Eur. J. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1007\/s12325-022-02198-y","article-title":"Lower risk of cardiovascular events in adult patients with chronic hypoparathyroidism treated with rpPTH(1\u201384): A retrospective cohort study","volume":"39","author":"Ayodele","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health -related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jbmr.3368","article-title":"Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: A case-control study","volume":"33","author":"Underbierg","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40618-018-0857-5","article-title":"Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism","volume":"41","author":"Meola","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1055\/s-0042-118181","article-title":"Long-term follow-up and treatment of postoperative permanent hypoparathyroidism in patients with medullary thyroid carcinoma: Differences in complete and partial disease","volume":"48","author":"Bruckner","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: A nationwide case finding study","volume":"30","author":"Underbierg","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e4098","DOI":"10.1210\/clinem\/dgac456","article-title":"Kidney complications and hospitalization in patients with chronic hypoparathyroidism: A cohort study in Sweden","volume":"107","author":"Swartling","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12020-025-04187-x","article-title":"Impaired renal function in patients with permanent hypoparathyroidism after thyroidectomy: Analysis of a nationwide cohort in Spain","volume":"88","author":"Anda","year":"2025","journal-title":"Endocrine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.surg.2024.05.005","article-title":"Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: A population-based study","volume":"176","author":"Luk","year":"2024","journal-title":"Surgery"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1007\/s12325-021-01787-7","article-title":"Risk of cardiovascular conditions in patients with chronic hypoparathyroidism: A retrospective cohort study","volume":"38","author":"Gosmanova","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: Etiologies and clinical features","volume":"101","author":"Shoback","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.3623","article-title":"Cardiovascular autonomic neuropathy as a new complication of postsurgical chronic hypoparathyroidism","volume":"34","author":"Tabacco","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jbmr.3329","article-title":"A population-based study of the epidemiology of chronic hypoparathyroidism","volume":"33","author":"Vadiveloo","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/JAHA.116.003815","article-title":"Calcium intake from diet and supplments and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the Multi-Ethnic Study of Atherosclerosis","volume":"5","author":"Anderson","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"f228","DOI":"10.1136\/bmj.f228","article-title":"Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study","volume":"346","author":"Melhus","year":"2013","journal-title":"BMJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2042098613499790","article-title":"Calcium supplements and cariovascular risk: 5 years on","volume":"4","author":"Bolland","year":"2013","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","unstructured":"(2025, January 10\u201313). European Society of Endocrinology. Proceedings of the Joint Congress of European Society of Paediatric Endocrinology (ESPE) and European Society of Endocrinology (ESE) 2025, Copenhagen, Denmark."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:37Z","timestamp":1760034397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":35,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165732"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165732","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}